Simcere Pharmaceutical's buy of Beijing Tobishi cleared conditionally in China
MLex Summary: Simcere Pharmaceutical’s acquisition of Beijing Tobishi Pharmaceutical has received conditional antitrust approval from China’s State Administration for Market Regulation. According to a decision published by the regulator, the deal...To view the full article, register now.
Already a subscriber? Click here to view full article